NCT03828162|Completed
Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly
Carebbean-e
Analysis of the Risk and Benefits of Anti-coagulation in Elderly Patients (>=75 Years)
Loading search results
Carebbean-e
Analysis of the Risk and Benefits of Anti-coagulation in Elderly Patients (>=75 Years)
Sponsor study identifier
observational
2,943
0 countries
N/A
Study Start
November 1, 2010
Actual (reported)Primary Completion
December 31, 2017
Actual (reported)Study Completion
December 31, 2018
Actual (reported)This study was designed to assess the effectiveness of oral anticoagulants in elderly patients (\>=75 years) with atrial fibrillation. All patients discharged from one large hospital in Stockholm, Danderyds Hospital, between november 1st 2010 and december 31st 2017 with atrial fibrillation as main diagnosis have been included (n=2943). Adverse events (cardiovascular death, fatal/non fatal ischemic stroke, peripheral thromboembolism, fatal/non fatal intracerebral hemorrhage and extracranial bleeding) are recorded through linkage to mandatory and qualitative national registries and review of the medical records until december 31 2018.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 1, 2010
Actual (reported)December 31, 2017
Actual (reported)December 31, 2018
Actual (reported)January 30, 2019
Actual (reported)February 4, 2019
Actual (reported)Ischemic stroke and peripheral embolism
Ischemic stroke and peripheral embolism have been defined according to the International Classification of Diseases (ICD-10) by the codes: ICD I63-I66. Data are extracted from the swedish national patients register.
2011-11-01 to 2018-12-31
Bleeding requiring hospitalization
Intracranial and extracranial bleeding have been defined according to the International Classification of Diseases (ICD-10) by the codes: ICD I63-I66. I60, I62, K25.0, K25.2, K25.4, K25.6, K29.0, K65, K92, N02, R19.5, R31, M62.2, N95.0, DR029). Data are extracted from the swedish national patients register.
2011-11-01 to 2018-12-31
Cardiovascular death
Cardiovascualr death is defined according to the International Classification of Diseases (ICD-10) by the codes:I00-I99. Data are extracted from the swedish national cause of death register.
2011-11-01 to 2018-12-31
Acute coronary syndrome
2011-11-01 to 2018-12-31
Heart failure
2011-11-01 to 2018-12-31
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Prospective cardiovascular cohort
Bruna Gigante, MD PhD
Karolinska Institutet
2,943 participants (actual enrollment reported by the registry).
First Submitted
January 30, 2019
First Posted
February 4, 2019
Study Start
November 1, 2010
Actual (reported)Restarting Anticoagulation After Traumatic Intracranial Hemorrhage
Contact the study team to confirm eligibility.
Primary Completion
December 31, 2017
Actual (reported)Study Completion
December 31, 2018
Actual (reported)Last Updated
February 4, 2019
Record last verified: 2019-01
Data will be shared according to the rules on privacy at Karolinska Institutet and according to General Data Protection Regulations in Europe. Individual data will not be shared, but summary statistics of the variable of interest will be provided upon request.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: